These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22452883)

  • 1. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.
    Wahdan-Alaswad RS; Bane KL; Song K; Shola DT; Garcia JA; Danielpour D
    Mol Cancer Res; 2012 Jun; 10(6):821-33. PubMed ID: 22452883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.
    Shola DT; Wang H; Wahdan-Alaswad R; Danielpour D
    Oncogene; 2012 May; 31(19):2480-90. PubMed ID: 21996749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.
    Wahdan-Alaswad RS; Song K; Krebs TL; Shola DT; Gomez JA; Matsuyama S; Danielpour D
    Cancer Res; 2010 Nov; 70(22):9106-17. PubMed ID: 21062988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
    Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
    J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
    Misra UK; Pizzo SV
    PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
    Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
    J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
    Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
    Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
    PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.
    Tsukamoto S; Mizuta T; Fujimoto M; Ohte S; Osawa K; Miyamoto A; Yoneyama K; Murata E; Machiya A; Jimi E; Kokabu S; Katagiri T
    Sci Rep; 2014 Dec; 4():7596. PubMed ID: 25534700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron.
    Wetzel P; Haag J; Câmpean V; Goldschmeding R; Atalla A; Amann K; Aigner T
    Kidney Int; 2006 Aug; 70(4):717-23. PubMed ID: 16807538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein 2 regulates cell-cell communication by down-regulating connexin43 expression in luteinized human granulosa cells.
    Wu YT; Chang HM; Huang HF; Sheng JZ; Leung PC
    Mol Hum Reprod; 2017 Mar; 23(3):155-165. PubMed ID: 27986931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis.
    Itman C; Loveland KL
    Dev Dyn; 2008 Jan; 237(1):97-111. PubMed ID: 18069690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTORC1 and BMP-Smad1/5 regulation of serum-stimulated myotube hypertrophy: a role for autophagy.
    Zhang Q; Halle JL; Counts BR; Pi M; Carson JA
    Am J Physiol Cell Physiol; 2024 Jul; 327(1):C124-C139. PubMed ID: 38766767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression.
    Kautz L; Meynard D; Besson-Fournier C; Darnaud V; Al Saati T; Coppin H; Roth MP
    Blood; 2009 Sep; 114(12):2515-20. PubMed ID: 19622835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5.
    Wei CY; Wang HP; Zhu ZY; Sun YH
    J Biol Chem; 2014 Mar; 289(10):6604-6618. PubMed ID: 24488494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
    Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
    J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Prostate Cancer DU-145 Cells Proliferation by
    Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G
    Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.
    Pangas SA; Li X; Umans L; Zwijsen A; Huylebroeck D; Gutierrez C; Wang D; Martin JF; Jamin SP; Behringer RR; Robertson EJ; Matzuk MM
    Mol Cell Biol; 2008 Jan; 28(1):248-57. PubMed ID: 17967875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
    Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
    Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
    Jiang SJ; Wang S
    Tumour Biol; 2015 Sep; 36(10):8177-84. PubMed ID: 25990456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.